Statistik Asas
| CIK | 1089029 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to CardioGenics Holdings Inc
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| February 26, 2024 |
CGNH / CardioGenics Holdings Inc / Iliad Research & Trading, L.P. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8)* CardioGenics Holdings Inc (Name of Issuer) Common Stock $0.00001 par value (Title of Class of Securities) 14160X203 (CUSIP Number) Calendar Year 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
| February 14, 2023 |
CGNH / CardioGenics Holdings Inc / Iliad Research & Trading, L.P. - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7)* CardioGenics Holdings Inc (Name of Issuer) Common Stock $0.00001 par value (Title of Class of Securities) 14160X203 (CUSIP Number) Calendar Year 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| February 7, 2022 |
CGNH / CardioGenics Holdings Inc / Iliad Research & Trading, L.P. - NONE Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)* CardioGenics Holdings Inc (Name of Issuer) Common Stock $0.00001 par value (Title of Class of Securities) 14160X203 (CUSIP Number) Calendar Year 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule |
|
| January 22, 2021 |
Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* CardioGenics Holdings Inc (Name of Issuer) Common Stock $0.00001 par value (Title of Class of Securities) 14160X203 (CUSIP Number) Calendar Year 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
| January 16, 2020 |
CGNH / CardioGenics Holdings Inc. / Iliad Research & Trading, L.P. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* CardioGenics Holdings Inc (Name of Issuer) Common Stock $0.00001 par value (Title of Class of Securities) 14160X203 (CUSIP Number) Calendar Year 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
| January 9, 2019 |
CGNH / CardioGenics Holdings Inc. / Iliad Research & Trading, L.P. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* CardioGenics Holdings Inc (Name of Issuer) Common Stock $0.00001 par value (Title of Class of Securities) 14160X203 (CUSIP Number) Calendar Year 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design |
|
| November 13, 2017 |
CGNH / CardioGenics Holdings Inc. / Iliad Research & Trading, L.P. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 02)* CardioGenics Holdings Inc (Name of Issuer) Common Stock $0.00001 par value (Title of Class of Securities) 14160X203 (CUSIP Number) Calendar Year 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desig |
|
| June 14, 2016 |
FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 14160X 203 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X] Form 10-Q [ ] Form N-SAR For Period Ended: Quarter ended April 30, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR [ ] Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| April 26, 2016 |
FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 26, 2016 CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (C |
|
| March 31, 2016 |
CGNH / CardioGenics Holdings Inc. / Iliad Research & Trading, L.P. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* CardioGenics Holdings Inc (Name of Issuer) Common Stock $0.00001 par value (Title of Class of Securities) 14160X203 (CUSIP Number) March 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
| March 28, 2016 |
CardioGenics Holdings (Quarterly Report) 10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended January 31, 2016. [ ] Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. |
|
| March 17, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 14160X 203 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X] Form 10-Q [ ] Form N-SAR For Period Ended: Quarter ended January 31, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR [ ] Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| February 26, 2016 |
CardioGenics Holdings (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended October 31, 2015 OR [ ] Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 000-28761 CARDIOGENICS HOLDING |
|
| January 29, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 14160X 203 NOTIFICATION OF LATE FILING (Check One): [X] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: October 31, 2015 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR [ ] Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| November 9, 2015 |
CardioGenics Enters into Asset Purchase Agreement to Acquire All Assets of Ontario-Based Plasticap EXHIBIT 99.1 CardioGenics Enters into Asset Purchase Agreement to Acquire All Assets of Ontario-Based Plasticap MISSISSAUGA, Ontario – November 4, 2015 – CardioGenics Holdings Inc. (OTCQB: CGNH), developer of the ultra-sensitive QL Care™ analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics (“IVD”) testing market, announced today that it, and its newly cr |
|
| November 9, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 9, 2015 CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commissi |
|
| October 19, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 19, 2015 CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commissi |
|
| October 5, 2015 |
CardioGenics Enters into Binding Letter of Intent to Acquire Assets of Ontario-Based Plasticap EXHIBIT 99.1 CardioGenics Enters into Binding Letter of Intent to Acquire Assets of Ontario-Based Plasticap MISSISSAUGA, Ontario ? October 5, 2015 ? CardioGenics Holdings Inc. (OTCQB: CGNH), developer of the ultra-sensitive QL Care? analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics (?IVD?) testing market, announced today that it has entered into a bin |
|
| October 5, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events 8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 5, 2015 CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction (Commissio |
|
| September 23, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended July 31, 2015. [ ] Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exact name of registr |
|
| September 14, 2015 |
FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 14160X 203 NOTIFICATION OF LATE FILING (Check One): ?[ ] Form 10-K ?[ ] Form 11-K ?[ ] Form 20-F ?[X] Form 10-Q ?[ ] Form N-SAR For Period Ended: Quarter ended July 31, 2015 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR [ ] Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| June 22, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended April 30, 2015. [ ] Transition report under Section 13 or 15(d) of the Exchange Act of 1934 For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exact name o |
|
| June 16, 2015 |
CGNH / CardioGenics Holdings Inc. / Iliad Research & Trading, L.P. - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* CardioGenics Holdings Inc (Name of Issuer) Common Stock $0.00001 par value (Title of Class of Securities) 14160X203 (CUSIP Number) June 16, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designat |
|
| June 15, 2015 |
FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 14160X 203 NOTIFICATION OF LATE FILING (Check One): ?[ ] Form 10-K ?[ ] Form 11-K ?[ ] Form 20-F ?[X] Form 10-Q ?[ ] Form N-SAR For Period Ended: Quarter ended April 30, 2015 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR [ ] Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| May 20, 2015 |
CGNH / CardioGenics Holdings Inc. / Lewner Charlie - SCHEDULE 13G Passive Investment SC 13G 1 sc13g051815lewnercardiogen.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) CardioGenics Holdings Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 14160X203 (CUSIP Number) February 23, 2015 (Date of Event which Requires Filing of th |
|
| March 24, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended January 31, 2015. [ ] Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. |
|
| March 17, 2015 |
FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 14160X 203 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X] Form 10-Q [ ] Form N-SAR For Period Ended: Quarter ended January 31, 2015 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR [ ] Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| February 19, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 19, 2015 CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incor |
|
| February 19, 2015 |
EXHIBIT 99.1 EXHIBIT 99.1 USPTO Issues Notice of Allowance in Connection with CardioGenics’ Self-Metering Cartridge Patent Application Self-Metering Cartridge is a Key Component of CardioGenics’ Ultra-Sensitive QL Care™ Analyzer MISSISSAUGA, Ontario – February 17, 2015 – CardioGenics Holdings Inc. (OTCQB: CGNH), developer of the ultra-sensitive QL Care™ analyzer, an immunoassay point-of-care analy |
|
| February 17, 2015 |
CGNH / CardioGenics Holdings Inc. / Saunders Paul H. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* CardioGenics Holdings Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 14160X203 (CUSIP Number) December 31, 2014 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designat |
|
| February 12, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K 10-K 1 form10-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended October 31, 2014 OR [ ] Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 000-28761 |
|
| February 5, 2015 |
Unregistered Sales of Equity Securities FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 5, 2015 CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) |
|
| January 29, 2015 |
CGNH / CardioGenics Holdings Inc. NT 10-K - - NT 10-K 1 nt10-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 14160X 203 NOTIFICATION OF LATE FILING (Check One): [X] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: October 31, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q [ ] Transition Report on For |
|
| January 12, 2015 |
CardioGenics Announces Appointment of New Director EXHIBIT 99.1 CardioGenics Announces Appointment of New Director MISSISSAUGA, Ontario – January 12, 2015 – CardioGenics Holdings Inc. (OTCQB: CGNH), developer of the ultra-sensitive QL Care™ analyzer, an immunoassay point-of-care analyzer, and other products for the In-Vitro-Diagnostics testing market, announced today that Karim Murabet has been appointed as a director of the Company, effective Jan |
|
| January 12, 2015 |
8-K 1 form8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 12, 2015 CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorpo |
|
| September 22, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended July 31, 2014. [ ] Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Ex |
|
| September 15, 2014 |
CGNH / CardioGenics Holdings Inc. NT 10-Q - - NOTIFICATION OF LATE FILING NT 10-Q 1 nt10-q.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 14160X 203 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 11-K [ ] Form 20-F [X] Form 10-Q [ ] Form N-SAR For Period Ended: Quarter ended July 31, 2014 [ ] Transition Report on Form 10-K [ ] Transition Report on |
|
| August 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 11, 2014 CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commissio |
|
| June 16, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended April 30, 2014. [ ] Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (E |
|
| June 13, 2014 |
EXHIBIT 10.1 EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of , 2014, is between Cardiogenics Holdings Inc., a Nevada corporation, (the “Company”), and the investor (the “Investor”), as set forth in the signature page to this Agreement. WHEREAS, the Company is executing and delivering this Agreement in reliance upon the exemption from se |
|
| June 13, 2014 |
FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 13, 2014 CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Co |
|
| June 13, 2014 |
EXHIBIT 99.1 EXHIBIT 99.1 CardioGenics Announces $1.3 Million Private Placement to European Investors Financing to Provide Growth Capital to Accelerate Beta-Site Testing and Commercialization of QL Care™ Analyzer and Troponin-I Test MISSISSAUGA, Ontario, June 12, 2014 (GLOBE NEWSWIRE) – CardioGenics Holdings Inc. (OTCBB: CGNH), developer of the QL Care™ analyzer, an ultra-sensitive immunoassay poi |
|
| March 17, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended January 31, 2014. [ ] Transition report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. |
|
| February 14, 2014 |
CGNH / CardioGenics Holdings Inc. / Saunders Paul H. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* CardioGenics Holdings Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 14160X203 (CUSIP Number) December 31, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designat |
|
| February 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended October 31, 2013 OR [ ] Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 000-28761 CARDIOGENICS HOLDING |
|
| January 30, 2014 |
NT 10-K 1 form12b-25.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 SEC File Number: 000-28761 CUSIP Number: 14160X 203 NOTIFICATION OF LATE FILING (Check One): [X] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: October 31, 2013 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 2 |
|
| October 3, 2013 |
Exhibit 10.1 Execution Version INVESTMENT AGREEMENT INVESTMENT AGREEMENT (this “AGREEMENT”), dated as of September 27, 2013 by and between CARDIOGENICS HOLDINGS INC. a Nevada corporation (the “Company”), and Dutchess Opportunity Fund, II, LP, a Delaware Limited Partnership (the “Investor”). WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the Investo |
|
| October 3, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2013 CardioGenics Holdings Inc. (Exact name of registrant as specified in its charter) Nevada 000-28761 88-0380546 (State or other jurisdiction (Commission (IRS Employer of |
|
| October 3, 2013 |
EX-10.2 3 ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 Execution Version REGISTRATION RIGHTS AGREEMENT Registration Rights Agreement (the “Agreement”), dated as of September 27, 2013, by and between CARDIOGENICS HOLDINGS INC., a corporation organized under the laws of Nevada (the “Company”), and Dutchess Opportunity Fund, II, LP, a Delaware Limited Partnership (the “Investor”). WHEREAS, in connection with |
|
| September 17, 2013 |
FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended July 31, 2013. [ ] Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number: 000-28761 CARDIOGENICS HOLDINGS INC. (Exact name |
|
| September 17, 2013 |
FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-28761 CUSIP Number: 14160X 203 (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: July 31, 2013 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Trans |
|
| August 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 10-Q/A 1 v34890310qa.htm FORM 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended April 30, 2013. ¨ Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-287 |
|
| June 20, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended April 30, 2013. o Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exact name of registrant |
|
| June 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 14160X 203 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨ Form 20-F x Form 10-Q ¨ Form N-SAR For Period Ended: Quarter ended April 30, 2013 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR ¨ Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| June 3, 2013 |
EXHIBIT 10.2 CARDIOGENICS HOLDINGS INC. 6295 Northam Drive, Unit 8 Mississauga, Ontario L4V 1W8 Canada Tel: 905.673.8501 Ÿ Fax: 905.673.9865 , 2013 Re: Interest Escrow Account / Series B Convertible Debenture No. SBCD- dated , 2013 in the Original Principal Amount of $ (the “Debenture”) Dear : This will confirm, as required by § 1 (b) of the Debenture, that CardioGenics Holdings Inc. (“CardioGenic |
|
| June 3, 2013 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits 8-K 1 v3434088k.htm 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 3, 2013 (May 31, 2013) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State |
|
| June 3, 2013 |
EX-10.1 2 v343408ex10-1.htm EXHIBIT 10.1 EXHIBIT 10.1 CONVERTIBLE DEBENTURE UNIT PURCHASE AGREEMENT FOR CARDIOGENICS HOLDINGS INC. OTCBB: CGNH ACCREDITED INVESTORS ONLY Number of Units Offered: Up to 15 Units Price per Unit: $100,000 Minimum Investment: One (1) Unit (Or Any Fractional Units Approved by the Company) Maximum Aggregate Subscription: $1,500,000 Each Unit consists of: One (1) Series B |
|
| March 25, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 ? Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended January 31, 2013. o Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exac |
|
| March 25, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 ? Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended October 31, 2012 OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 000-28761 CARDIO |
|
| March 18, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended January 31, 2013. o Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exact name of registra |
|
| March 4, 2013 |
EXHIBIT 10.1 CONVERTIBLE DEBENTURE UNIT PURCHASE AGREEMENT FOR CARDIOGENICS HOLDINGS INC. OTCBB: CGNH ACCREDITED INVESTORS ONLY Number of Units Offered: 40 Price per Unit: $25,000 Minimum Investment: One (1) Unit Maximum Aggregate Subscription: $1,000,000 Each Unit consists of: One (1) Series A Convertible Debenture in the Original Principal Amount of $25,000; and One (1) Warrant to Purchase Fifty |
|
| March 4, 2013 |
Unregistered Sales of Equity Securities, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 4, 2013 (February 27, 2013) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorpo |
|
| February 28, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 28, 2013 (February 25, 2013) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of inc |
|
| February 14, 2013 |
CGNH / CardioGenics Holdings Inc. / Saunders Paul H. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* ???????? CardioGenics Holdings Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 14160X203 (CUSIP Number) December 31, 2012 (Date of Event which Requires Filing of this Statement) Check the appropriate box to |
|
| January 29, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended October 31, 2012 OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 000-28761 CARDIOGENICS HOLDINGS IN |
|
| January 18, 2013 |
*090201* *090201* ROSS MILLER Secretary of State 204 North Carson Street, Suite 1 Carson City, Nevada 89701-4520 (775) 684-5708 Website: www. |
|
| January 18, 2013 |
8-K 1 v3320568k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 18, 2013 (January 17, 2013) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State o |
|
| December 26, 2012 |
EXHIBIT 16.2 CardioGenics Holdings Inc. (A Development Stage Company) Report of Independent Registered Public Accounting Firm To the Board of Directors and Stockholders of CardioGenics Holdings Inc. We have audited the accompanying consolidated balance sheet of CardioGenics Holdings Inc. (a development stage company) as of October 31, 2011, and the related consolidated statements of operations, ch |
|
| December 26, 2012 |
EX-16.1 2 v330863ex16-1.htm EXHIBIT 16.1 EXHIBIT 16.1 KPMG LLP Telephone (416) 777-8500 Chartered Accountants Fax (416) 777-8818 Bay Adelaide Centre Internet www.kpmg.ca 333 Bay Street Suite 4600 Toronto ON M5H 2S5 December 26, 2012 Securities and Exchange Commission Washington, D.C. 20549 Ladies and Gentlemen: We were previously principal accountants for CardioGenics Holdings Inc. and, under the |
|
| December 26, 2012 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant 8-K 1 v3308638k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 26, 2012 (December 18, 2012) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State |
|
| October 23, 2012 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 23, 2012 (October 17, 2012) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incor |
|
| September 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended July 31, 2012. ? Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exact name of registrant |
|
| September 14, 2012 |
AMENDMENT TO BY-LAWS CARDIOGENICS HOLDINGS INC. EXHIBIT 3.1 AMENDMENT TO BY-LAWS OF CARDIOGENICS HOLDINGS INC. By Unanimous Written Consent of the Board of Directors of CardioGenics Holdings Inc., a Nevada Corporation (the “Corporation”) given on September 10, 2012, the By-Laws of the Corporation (the “By-Laws”), are hereby amended as follows, effective September 10, 2012: 1. ARTICLE I, Section .01 of the By-Laws is deleted in its entirety and |
|
| September 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 14, 2012 (September 10, 2012) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of i |
|
| September 14, 2012 |
DEF 14A 1 v322147def14a.htm FORM DEF 14A U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION INFORMATION REQUIRED IN PROXY STATEMENT Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the Appropriate Box: ¨ Preliminary Proxy Statement ¨ Confidential, for Us |
|
| August 10, 2012 |
SHULMAN, ROGERS, GANDAL, PORDY & ECKER, P.A. scott d. museles | attorney at law T 301.230.5246 E [email protected] August 10, 2012 Ms. Mills-Apenteng Special Counsel United States Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: CardioGenics Holdings Inc. Preliminary Schedule 14A Filed on July 13, 2012 Dear Ms. Mills-Apenteng: This letter is being submitted i |
|
| July 13, 2012 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION INFORMATION REQUIRED IN PROXY STATEMENT Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the Appropriate Box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by |
|
| June 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 v31531810q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended April 30, 2012. o Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDING |
|
| April 20, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 3 ? Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended October 31, 2011 OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 000-28761 CARDIO |
|
| April 16, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended January 31, 2012. ¨ Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exac |
|
| April 16, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 2 þ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended October 31, 2011 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 000-28761 CARDIO |
|
| April 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended January 31, 2012. ? Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exact name of registra |
|
| March 20, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 19, 2012 (March 16, 2012) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorpora |
|
| March 20, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 14160X 203 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨ Form 20-F x Form 10-Q ¨ Form N-SAR For Period Ended: Quarter ended January 31, 2012 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR ¨ Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| March 5, 2012 |
SCHEDULE 14C INFORMATION (RULE 14C-101) Information Statement Pursuant to Section 14 (c) Of the Securities Exchange Act of 1934 Check the appropriate box: S Preliminary Information Statement ¨ Definitive Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d) (2) CARDIOGENICS HOLDINGS INC. |
|
| February 24, 2012 |
EXHIBIT 16.1 February 24, 2012 Securities and Exchange Commission 450 Fifth Street, NW Washington, DC 20549 Re: CardioGenics Holdings Inc. File No. 000-28761 Dear Sirs: On February 20, 2012, we were informed that we were dismissed as the independent registered public accountants for CardioGenics Holdings Inc. We have read the statements included under Item 4.01, Changes in Registrant’s Certifying |
|
| February 24, 2012 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant 8-K 1 v3034628k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 24, 2012 (February 20, 2012) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other |
|
| February 14, 2012 |
CGNH / CardioGenics Holdings Inc. / Saunders Paul H. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* ???????? CardioGenics Holdings Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 14160X203 (CUSIP Number) December 31, 2011 (Date of Event which Requires Filing of this Statement) Check the appropriate box to |
|
| February 1, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 þ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended October 31, 2011 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 000-28761 CARDIO |
|
| January 30, 2012 |
10-K 1 v24541910k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended October 31, 2011 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 00 |
|
| January 27, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended October 31, 2010 OR Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 000-28761 CARDIOGENI |
|
| January 27, 2012 |
EXHIBIT 31.1(b) SECTION 302 CERTIFICATION (Amended) I, Yahia Gawad, certify that: 1. I have reviewed this Annual Report on Form 10-K for the period ended October 31, 2010 of CardioGenics Holdings Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances u |
|
| January 27, 2012 |
Exhibit 31.1(a) CERTIFICATIONS I, Yahia Gawad, certify that: 1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of CardioGenics Holdings Inc.; and 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were |
|
| January 27, 2012 |
EXHIBIT 31.2 (b) SECTION 302 CERTIFICATION (Amended) I, James Essex, certify that: 1. I have reviewed this Annual Report on Form 10-K for the period ended October 31, 2010 of CardioGenics Holdings Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances |
|
| January 27, 2012 |
Exhibit 31.2(a) CERTIFICATIONS I, James Essex, certify that: 1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of CardioGenics Holdings Inc.; and 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were |
|
| September 23, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 ? Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended JULY 31, 2011. o Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exact n |
|
| September 19, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended JULY 31, 2011. ¨ Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exact name of registrant |
|
| September 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 14160X 203 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 11-K ? Form 20-F x Form 10-Q ? Form N-SAR For Period Ended: Quarter ended July 31, 2011 ? Transition Report on Form 10-K ? Transition Report on Form 10-Q ? Transition Report on Form 20-F ? Transition Report on Form N-SAR ? Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| July 6, 2011 |
6295 Northam Drive, Unit 8 Mississauga, Ontario L4V 1W8 T: 905.673.8501 • F: 905.673.9865 6295 Northam Drive, Unit 8 Mississauga, Ontario L4V 1W8 T: 905.673.8501 • F: 905.673.9865 June 30, 2011 Mr. Stephen Krikorian Accounting Branch Chief Securities and Exchange Commission Washington, D.C. 20549 Re: CardioGenics Holdings, Inc. Form 10-K for the Fiscal Year Ended October 31, 2010 Filed January 31, 2011 File No. 000-28761 Dear Mr. Krikorian: I am writing in reply to your letter of June |
|
| June 22, 2011 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 22, 2011 (June 21, 2011) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporati |
|
| June 22, 2011 |
EXHIBIT 99.1 CardioGenics Transfers Magnetic Beads Business Unit Into its Luxspheres Inc. Subsidiary Luxspheres to Focus on the Further Development and Marketing of CardioGenics? SAVAsphere? Magnetic Beads MISSISSAUGA, Ontario ? June 22, 2011 ? CardioGenics Holdings Inc. (CGNH.OB) announced today the transfer of its magnetic beads business unit, which develops ultra sensitive magnetic beads for us |
|
| June 22, 2011 |
INTELLECTUAL PROPERTY ASSIGNMENT & LICENSE AGREEMENT EXHIBIT 10.1 INTELLECTUAL PROPERTY ASSIGNMENT & LICENSE AGREEMENT THIS INTELLECTUAL PROPERTY ASSIGNMENT & LICENSE AGREEMENT (this ?Agreement?) is made and dated as of June 21, 2011 (the ?Effective Date?) by and between CARDIOGENICS INC., an Ontario corporation with its principal office and place of business at 6295 Northam Drive, Unit 8, Mississauga, Ontario L4V 1W8 Canada (?CardioGenics?) and LUX |
|
| June 20, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended APRIL 30, 2011. o Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exact name of registrant |
|
| June 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 14160X 203 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨ Form 20-F x Form 10-Q ¨ Form N-SAR For Period Ended: Quarter ended April 30, 2011 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR ¨ Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| March 17, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended JANUARY 31, 2011. o Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exact name of registra |
|
| March 2, 2011 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 2, 2011 (February 28, 2011) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorpo |
|
| March 2, 2011 |
EXHIBIT 10.2 REDEMPTION NOTICE Series 3 Class B Common Stock (Par Value $0.00001) CARDIOGENICS HOLDINGS INC. 6295 Northam Drive, Unit 8 ? Mississauga Ontario L4V 1W8 T: 905.673.8501 ? F: 905.673.9865 redemption @cardiogenics.com February 25, 2011 To: The Holders of CardioGenics Holdings Inc. Series 3 Class B Common Stock (?Series 3 CL B Shares?) This will serve as notice that CardioGenics Holdings |
|
| March 2, 2011 |
EXHIBIT 10.1 REDEMPTION NOTICE Series 2 Class B Common Stock (Par Value $0.00001) CARDIOGENICS HOLDINGS INC. 6295 Northam Drive, Unit 8 ? Mississauga Ontario L4V 1W8 T: 905.673.8501 ? F: 905.673.9865 redemption @cardiogenics.com February 25, 2011 To: The Holders of CardioGenics Holdings Inc. Series 2 Class B Common Stock (?Series 2 CL B Shares?) This will serve as notice that CardioGenics Holdings |
|
| March 1, 2011 |
SCHEDULE 14C INFORMATION (RULE 14C-101) Information Statement Pursuant to Section 14 (c) Of the Securities Exchange Act of 1934 Check the appropriate box: ¨ Preliminary Information Statement x Definitive Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d) (2) CARDIOGENICS HOLDINGS INC. |
|
| January 31, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended October 31, 2010 OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 000-28761 CARDIOGENICS HOLDINGS IN |
|
| January 31, 2011 |
SUBSIDIARIES OF CARDIOGENICS HOLDINGS INC. EXHIBIT 21.1 SUBSIDIARIES OF CARDIOGENICS HOLDINGS INC. Name Jurisdiction of Organization Percentage Ownership CardioGenics CallCo Inc. Ontario, Canada 100% CardioGenics ExchangeCo Inc. Ontario, Canada 100%1 CardioGenics Inc. Ontario, Canada 99%2 Luxspheres Inc. Ontario, Canada 100%3 CardioGenics Acquisition Inc. Delaware 100% 1Owned indirectly through CardioGenics CallCo Inc., which owns 100% of |
|
| December 22, 2010 |
6295 Northam Drive, Unit 8 Mississauga, Ontario L4V 1W8 T: 905.673.8501 • F: 905.673.9865 EXHIBIT 10.1 6295 Northam Drive, Unit 8 Mississauga, Ontario L4V 1W8 T: 905.673.8501 ? F: 905.673.9865 December 21, 2010 Chandra Panchal 303 Baffin, Dollard Des-Ormeaux Quebec H9A 3G4 Canada Re: Lock-Up Agreement Dated March 23, 2010 between CardioGenics Holdings Inc. and Chandra Panchal (the ?Lock-up Agreement?) Dear Chandra: This will confirm our understanding that the Lock-Up Agreement, pursuan |
|
| December 22, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 22, 2010 (December 21, 2010) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of inc |
|
| November 4, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 4, 2010 (November 3, 2010) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incor |
|
| November 4, 2010 |
CardioGenics Raises $1.9 Million in Private Placement EX-99.1 3 v200990ex99-1.htm EXHIBIT 99.1 CardioGenics Raises $1.9 Million in Private Placement Mississauga, Ontario, November 4, 2010 – CardioGenics Holdings Inc. (OTCBB: CGNH) announced today that it has completed a private placement under which it has raised $1,930,575. The shares issued in connection with the private placement do not have registration rights and are, therefore, subject to the r |
|
| November 4, 2010 |
EXHIBIT 10.1 THE SECURITIES TO WHICH THIS PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT RELATES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, SUCH SECURITIES MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE R |
|
| October 22, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ???????? CardioGenics Holdings Inc. (Name of Issuer) Common stock, par value $0.001 per share (Title of Class of Securities) 14160X203 (CUSIP Number) August 11, 2010 (Date of Event which Requires Filing of this Statement) Check the appropriate box to desi |
|
| September 14, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended JULY 31, 2010. o Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exact name of registrant |
|
| August 19, 2010 |
SCHEDULE 14C INFORMATION (RULE 14C-101) Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 Check the appropriate box: o Preliminary Information Statement x Definitive Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d) (2) CARDIOGENICS HOLDINGS INC. |
|
| July 15, 2010 |
CardioGenics And Merck In Second Product Agreement EXHIBIT 99.1 CardioGenics And Merck In Second Product Agreement CardioGenics Extends its Partnership with Merck Chimie by Entering into a Second Agreement to Link Biological Material to Merck Chimie?s Magnetic Particles for Antibody Manufacturing: Deal Deepens Company?s Involvement In Merck?s Magnetic Bead Programs MISSISSAUGA, Ontario, July 14, 2010 - CardioGenics Holdings Inc. (OTCBB: CGNHD), de |
|
| July 15, 2010 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 15, 2010 (July 12, 2010) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporati |
|
| June 23, 2010 |
EXHIBIT 99.1 CardioGenics Announces Reverse Stock Split Authorized and Outstanding Common Shares Reverse Split on a 1:10 Basis Mississauga, Ontario, June 18, 2010 - CardioGenics Holdings Inc. (OTCBB: CGNH), developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced today that the Company has filed a |
|
| June 23, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 23, 2010 (June 18, 2010) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporati |
|
| June 23, 2010 |
EXHIBIT 3.1 ROSS MILLER Secretary of State 204 North Carson Street, Suite 1 Carson City, Nevada 89701-4520 (775) 684-5708 Website: www.nvsos.gov *90301* Certificate of Change Pursuant to NRS 78.209 USE BLACK INK ONLY- DO NOT HIGHLIGHT ABOVE SPACE IS FOR OFFICE USE ONLY Certificate of Change filed Pursuant to NRS 78.209 For Nevada Profit Corporations 1. Name of corporation: CardioGenics Holdings In |
|
| June 14, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended APRIL 30, 2010. o Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exact name of registrant |
|
| March 25, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 25, 2010 (March 22, 2010) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorpora |
|
| March 25, 2010 |
EXHIBIT 10.2 Lock-Up Agreement THIS LOCK-UP AGREEMENT (this “Agreement”) is entered into as of March , 2010 by and between (the “Stockholder”) and CARDIOGENICS HOLDINGS INC. a Nevada corporation (the “Company”). WHEREAS, Stockholder holds common stock, $0.00001 par value per share, of the Company (the “Common Stock”); WHEREAS, the Company believes it is in the best interests of its stockholders to |
|
| March 25, 2010 |
EXHIBIT 10.1 Lock-Up Agreement THIS LOCK-UP AGREEMENT (this ?Agreement?) is entered into as of March , 2010 among (the ?Stockholder?), CARDIOGENICS HOLDINGS INC. a Nevada corporation (the ?Company?), CardioGenics ExchangeCo Inc., an Ontario corporation (?ExchangeCo?) and WeirFoulds LLP, as ?trustee?, under the ?Trust Agreement? described below. WHEREAS, Stockholder holds common stock of CardioGeni |
|
| March 25, 2010 |
EXHIBIT 99.1 CardioGenics Announces Lock-Up Agreements with Board Members, Executives and Certain Other Stockholders Directors, Executives and Stockholders Lock-Up 53,144,943 Shares until September 22, 2011 Mississauga, Ontario March 25, 2010 — CardioGenics Holdings Inc. (OTC BB: CGNH), a developer of technology and products targeting the Point-Of-Care (POC) segment of the IVD market announced tod |
|
| March 22, 2010 |
EXHIBIT 10.1 CardioGenics Holdings Inc. 6295 Northam Drive, Unit 8 Mississauga, Ontario L4V 1W8 T: 905.673.8501 ? F: 905.673.9865 March 19, 2009 YA Global Master SPV Ltd. 101 Hudson Street, Suite 3700 Jersey City, NJ 07302 Attention: Mark Angelo, Portfolio Manager Re: Standby Equity Distribution Agreement dated March 12, 2009 between CardioGenics Holdings Inc. (formerly JAG Media Holdings, Inc.) a |
|
| March 22, 2010 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 22, 2010 (March 19, 2010) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorpora |
|
| March 17, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended January 31, 2010. o Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 CARDIOGENICS HOLDINGS INC. (Exact name of registra |
|
| March 16, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 16, 2010 (March 15, 2010) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorpora |
|
| March 16, 2010 |
EXHIBIT 99.1 CardioGenics Announces Lock-Up Agreement with Dr. Yahia Gawad Chief Executive Officer of CardioGenics Locks-Up 150,000,000 shares until March 15, 2014 Mississauga, Ontario – March 16, 2010 — CardioGenics Holdings Inc. (OTC BB: CGNH), a developer of technology and products targeting the Point-Of-Care (POC) segment of the IVD market announced today that the Company has entered into a lo |
|
| March 16, 2010 |
EXHIBIT 10.1 Lock-Up Agreement THIS LOCK-UP AGREEMENT (this “Agreement”) is entered into as of March 15, 2010 among Yahia Gawad (the “Gawad”), CARDIOGENICS HOLDINGS INC. a Nevada corporation (the “Company”), CardioGenics ExchangeCo Inc., an Ontario corporation (“ExchangeCo”) and WeirFoulds LLP, as “trustee“, under the “Trust Agreement described below. WHEREAS, Gawad holds common stock of CardioGen |
|
| February 16, 2010 |
Exhibit 10.28 RETAINER AGREEMENT CardioGenics Holdings Inc. (OTCBB:CGNH) ("the Client") engages Wolfe Axelrod Weinberger Associates LLC (?WAW?), as its investor relations firm for a program of financial communications and investor relations. This agreement is intended to memorialize the duties and responsibilities of the parties with respect to such services and Information (as defined below) conc |
|
| February 16, 2010 |
EXHIBIT 10.31 LLC MEMBERSHIP INTEREST PURCHASE AGREEMENT BETWEEN CARDIOGENICS HOLDINGS INC. AS SELLER AND ROTHCOVE PARTNERS LLC AS BUYER February 10, 2010 TABLE OF CONTENTS 1. PURCHASE OF LLC INTERESTS 4 1.1 Sale of the LLC Interests 4 1.2 Purchase Price 4 2. CLOSING 4 2.1 Closing 4 2.2 Actions of Seller at Closing 4 2.3 Actions of Buyer at Closing 4 2.4 Taking of Necessary Action; Further Action |
|
| February 16, 2010 |
SUBSIDIARIES OF CARDIOGENICS HOLDINGS INC. EXHIBIT 21.1 SUBSIDIARIES OF CARDIOGENICS HOLDINGS INC. Name Jurisdiction of Organization Percentage Ownership CardioGenics CallCo Inc. Ontario, Canada 100% CardioGenics ExchangeCo Inc. Ontario, Canada 100%1 CardioGenics Inc. Ontario, Canada 99%2 Luxspheres Inc. Ontario, Canada 100%3 JAG Media Acquisition Inc. Delaware 100% 1Owned indirectly through CardioGenics CallCo Inc., which owns 100% of Car |
|
| February 16, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended October 31, 2009 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 000-28761 CARDIOGENICS HOLDINGS IN |
|
| February 16, 2010 |
EXECUTIVE EMPLOYMENT AGREEMENT EXHIBIT 10.30 EXECUTIVE EMPLOYMENT AGREEMENT THIS AGREEMENT made as of the 31st day of July, 2009. BETWEEN: CARDIOGENICS INC., (hereinafter referred to as the "Corporation"), - and - - YAHIA A. GAWAD, MD, (hereinafter referred to as the "Executive"), WHEREAS the Corporation has offered employment to the Executive in the capacity of Chief Executive Officer, and the Executive has accepted such offer |
|
| February 16, 2010 |
THE INVESTOR RELATIONS GROUP INC. LETTER OF AGREEMENT Date: January 18, 2010 EXHIBIT 10.29 THE INVESTOR RELATIONS GROUP INC. LETTER OF AGREEMENT Date: January 18, 2010 Section 1. Services to be Rendered. (a) The purpose of this letter is to set forth the terms and conditions on which The Investor Relations Group, Inc. (“IRG“) agrees to provide CardioGenics Holdings Inc. (the “Company”) a comprehensive public relations program. These services may include, but are not limite |
|
| February 9, 2010 |
Page 1 OMB APROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response…10/4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 29, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 SEC File Number: 000-28761 CUSIP Number: 14160X 104 NOTIFICATION OF LATE FILING (Check One): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form N-SAR o Form N-CSR For Period Ended: Fiscal Year ended October 31, 2009 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transition Report on Form 10-Q o Transition Report on Form N-SAR For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| November 27, 2009 |
EXHIBIT 99.1 CardioGenics Provides Update on Agreement with Merck Chimie for its Silver Coated Paramagnetic Beads Merck Chimie Has Successfully Completed Encapsulation of CardioGenics? Beads and is Progressing to the Next Phase of Commercialization MISSISSAUGA, Ontario, November 24, 2009- CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH), a developer of technology and products targeting the im |
|
| November 27, 2009 |
Financial Statements and Exhibits, Other Events, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 25, 2009 (November 20, 2009) CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of inc |
|
| October 2, 2009 |
EXHIBIT 99.1 CardioGenics Holdings Inc. Engages Gilford Securities As Investment Banker Gilford?s Healthcare Banking Group to Provide Specialized Investment Banking Services Mississauga, Ontario, October 2, 2009 ? CardioGenics Holdings Inc. (OTCBB: JAGH) has entered into an agreement with Gilford Securities Incorporated (?Gilford?), pursuant to which Gilford will provide investment banking service |
|
| October 2, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 2, 2009 CardioGenics Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commissio |
|
| September 21, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended July 31, 2009. o Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 JAG MEDIA HOLDINGS, INC. (Exact name of registrant as |
|
| September 15, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 470080409 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨ Form 20-F x Form 10-Q ¨ Form N-SAR For Period Ended: Quarter ended July 31, 2009 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR ¨ Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| September 11, 2009 |
JAG Media Holdings, Inc. Announces Agreement with The Investor Relations Group, Inc. IRG to Provide U.S. Investor Relations and Public Relations Services Mississauga, Ontario, September 11, 2009 - JAG Media Holdings, Inc. (OTCBB: JAGH) has entered into an agreement with The Investor Relations Group, Inc. (“IRG”), pursuant to which IRG will provide various investor relations and public relations se |
|
| September 11, 2009 |
THE INVESTOR RELATIONS GROUP INC. LETTER OF AGREEMENT Date: September 10, 2009 THE INVESTOR RELATIONS GROUP INC. LETTER OF AGREEMENT Date: September 10, 2009 Section 1. Services to be Rendered. The purpose of this letter is to set forth the terms and conditions on which The Investor Relations Group, Inc. (IRG) agrees to provide JAG Media Holdings, Inc. (which is in the process of changing its corporate name to CardioGenics Holdings Inc.) (the “Company”) a comprehensive corpo |
|
| September 11, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 11, 2009 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commissi |
|
| September 9, 2009 |
SCHEDULE 14C (RULE 14C-101) Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 Check the appropriate box: o Preliminary Information Statement x Definitive Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d) (2) JAG MEDIA HOLDINGS, INC. |
|
| September 4, 2009 |
BDO Dunwoody LLP Chartered Accountants and Advisors Royal Bank Plaza P.O. Box 32 Toronto, Ontario, Canada M5J 2J8 Telephone: (416) 865-0200 Telefax: (416) 865-0887 September 2, 2009 Office of the Chief Accountant SECPS Letter File Mail Stop 9-5 Securities and Exchange Commission 450 Fifth Street, NW Washington, DC 20549 Re: JAG Media Holdings, Inc. File No. 000-28761 We have read the statements th |
|
| September 4, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 4, 2009 (August 31, 2009) JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorpo |
|
| August 10, 2009 |
EXHIBIT 99.2 CardioGenics Inc. Consolidated Financial Statements October 31, 2008 and 2007 With Independent Auditors? Report (Expressed in US Dollars) CardioGenics Inc. (A Development Stage Company) Table of Contents October 31, 2008 and 2007 Independent Auditors? Report 1 Consolidated Financial Statements Balance Sheets 2 Statements of Operations and Deficit 3 Statements of Stockholders? Deficien |
|
| August 10, 2009 |
UNAUDITED PRO FORMA CONDENSED FINANCIAL INFORMATION EXHIBIT 99.3 UNAUDITED PRO FORMA CONDENSED FINANCIAL INFORMATION The following unaudited condensed pro forma financial statements of JAG Media and CardioGenics were derived from the historical consolidated financial statements of JAG Media and CardioGenics and should be read in conjunction with the historical financial statements and the notes thereto, included elsewhere in this Current Report on |
|
| August 10, 2009 |
JAG Media Holdings, Inc. Announces Completion of Acquisition of CardioGenics Inc. EXHIBIT 99.1 Contact: Stephen J. Schoepfer (609) 945-0405 [email protected] JAG Media Holdings, Inc. Announces Completion of Acquisition of CardioGenics Inc. Mississauga, Ontario, July 31, 2009 - JAG Media Holdings, Inc. (OTCBB: JAGH) announced today that it has completed the acquisition of CardioGenics Inc. by JAG Media’s Ontario, Canada subsidiary, CardioGenics ExchangeCo Inc. In connection w |
|
| August 10, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 10, 2009 (July 31, 2009) JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorpora |
|
| August 3, 2009 |
JAG Media Holdings, Inc. Announces Completion of Acquisition of CardioGenics Inc. EXHIBIT 99.1 Contact: Stephen J. Schoepfer (609) 945-0405 [email protected] JAG Media Holdings, Inc. Announces Completion of Acquisition of CardioGenics Inc. Mississauga, Ontario, July 31, 2009 - JAG Media Holdings, Inc. (OTCBB: JAGH) announced today that it has completed the acquisition of CardioGenics Inc. by JAG Media’s Ontario, Canada subsidiary, CardioGenics ExchangeCo Inc. In connection w |
|
| August 3, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 3, 2009 (July 31, 2009) JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporatio |
|
| July 24, 2009 | ||
| July 24, 2009 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 24, 2009 (July 23, 2009) JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdictio |
|
| July 24, 2009 |
Stephen J. Schoepfer, President & COO JAG Media Holdings, Inc. (609) 945-0405 [email protected] JAG Media Holdings, Inc. Announces a Further Update of the Status of Its Acquisition of CardioGenics Inc. Boca Raton, FL, July 24, 2009 - - JAG Media Holdings, Inc. (OTCBB: JAGH) announced today a further update of the status of its acquisition of CardioGenics Inc. by its Ontario, Canada subsidiary, Ca |
|
| July 20, 2009 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 20, 2009 (July 14, 2009) JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdictio |
|
| July 20, 2009 | ||
| July 20, 2009 |
EX-99.2 36 ex99-2.htm PRESS RELEASE EXHIBIT 99.2 Stephen J. Schoepfer, President & COO JAG Media Holdings, Inc. (609) 945-0405 [email protected] JAG Media Holdings, Inc. Announces a Further Update of the Status of Its Acquisition of CardioGenics Inc. Boca Raton, FL, July 16, 2009 - JAG Media Holdings, Inc. (OTCBB: JAGH) announced today a further update of the status of its acquisition of CardioGe |
|
| July 6, 2009 |
VOTING AND EXCHANGE TRUST AGREEMENT VOTING AND EXCHANGE TRUST AGREEMENT THIS VOTING AND EXCHANGE TRUST AGREEMENT is entered into as of July 6, 2009, by and between JAG Media Holdings, Inc. |
|
| July 6, 2009 |
Stephen J. Schoepfer, President & COO JAG Media Holdings, Inc. (609) 945-0405 [email protected] JAG Media Holdings, Inc. Announces a Further Update of the Status of Its Acquisition of CardioGenics Inc. Boca Raton, FL, June 30, 2009 - - JAG Media Holdings, Inc. (OTCBB: JAGH) announced today a further update of the status of its acquisition of CardioGenics Inc. by its Ontario, Canada subsidiary, Ca |
|
| July 6, 2009 |
SUPPORT AGREEMENT THIS SUPPORT AGREEMENT is entered into as of July 6, 2009, between JAG Media Holdings, Inc. |
|
| July 6, 2009 |
Other Events, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 30, 2009 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commission Fi |
|
| June 19, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Schedule 14f-1 INFORMATION STATEMENT PURSUANT TO SECTION 14(f) OF THE SECURITIES EXCHANGE ACT OF 1934 JAG MEDIA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Commission File No.:000-28761 Nevada 88-0380546 (State or other jurisdiction ofIncorporation or Organization) (I.R.S. Employer Identification No.) |
|
| June 18, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended April 30, 2009. o Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 JAG MEDIA HOLDINGS, INC. (Exact name of registrant a |
|
| June 16, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 470080409 NOTIFICATION OF LATE FILING (Check One): o Form 10-K o Form 11-K o Form 20-F x Form 10-Q o Form N-SAR For Period Ended: Quarter ended April 30, 2009 o Transition Report on Form 10-K o Transition Report on Form 10-Q o Transition Report on Form 20-F o Transition Report on Form N-SAR o Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| June 4, 2009 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 29, 2009 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commission Fil |
|
| June 4, 2009 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 May 29, 2009 YA Global Investments, L.P. 101 Hudson Street, Suite 3700 Jersey City, NJ 07302 Re: Warrants to purchase shares of JAG Media Holdings, Inc. (?JAG Media?) held by YA Global Investments, L.P. (?YA Global?). Gentlemen: This letter shall set forth our understanding with respect to the warrant (the "Warrant") is |
|
| May 22, 2009 |
SHARE PURCHASE AGREEMENT BETWEEN JAG MEDIA HOLDINGS, INC., CARDIOGENICS EXCHANGECO INC., CARDIOGENICS INC. AND YAHIA GAWAD, PRINCIPAL SHAREHOLDER OF CARDIOGENICS INC. MAY 22, 2009 TABLE OF CONTENTS Page ARTICLE 1 INTERPRETATION 2 1.1 Definitions 2 1.2 Headings and References 8 1.3 Entire Agreement 8 1.4 Applicable Law 8 1.5 Statutes 8 1.6 Number and Gender 8 1.7 Currency 9 1.8 Knowledge 9 1.9 Anne |
|
| May 22, 2009 |
Stephen J. Schoepfer, President & COO JAG Media Holdings, Inc. (609) 945-0405 [email protected] JAG Media Holdings, Inc. Announces Definitive Share Purchase Agreement in Connection with Its Proposed Acquisition of CardioGenics Inc. Boca Raton, FL, May 22, 2009 - JAG Media Holdings, Inc. (OTCBB: JAGH) announced today that it and its newly created Canadian subsidiary, CardioGenics Exchangeco Inc., |
|
| May 22, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 22, 2009 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commission Fil |
|
| May 5, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2009 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commission File |
|
| May 5, 2009 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 April 29, 2009 YA Global Investments, L.P. 101 Hudson Street, Suite 3700 Jersey City, NJ 07302 Re: Warrants to purchase shares of JAG Media Holdings, Inc. (“JAG Media”) held by YA Global Investments, L.P. (“YA Global”). Gentlemen: This letter shall set forth our understanding with respect to the warrant (the "Warrant") |
|
| March 20, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended January 31, 2009. ¨ Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 JAG MEDIA HOLDINGS, INC. (Exact name of registrant |
|
| March 18, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SEC File Number: 000-28761 CUSIP Number: 470080409 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨Form 20-F ýForm 10-Q ¨Form N-SAR For Period Ended: Quarter ended January 31, 2009 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR ¨ Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| March 13, 2009 |
Term Sheet JAG Media Holdings, Inc. (OTCBB: JAGH) and CardioGenics Inc. Acquisition of CardioGenics Inc. by CardioGenics ExchangeCo, Inc., A To Be Created Wholly Owned Subsidiary of CardioGenics CallCo, Inc., a To Be Created Wholly-Owned Subsidiary of JAG Media Holdings, Inc. 1. Target: CardioGenics Inc., a corporation organized under the laws of the Province of Ontario Canada, having a principal |
|
| March 13, 2009 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 March 12, 2009 YA Global Investments, L.P. 101 Hudson Street, Suite 3700 Jersey City, NJ 07302 Re: Warrants to purchase shares of JAG Media Holdings, Inc. (“JAG Media”) held by YA Global Investments, L.P. (“YA Global”). Gentlemen: This letter shall set forth our understanding with respect to the warrant (the "Warrant") |
|
| March 13, 2009 |
Stephen J. Schoepfer, President & COO JAG Media Holdings, Inc. (609) 945-0405 [email protected] JAG Media Holdings, Inc. Announces Letter of Intent for the Acquisition of CardioGenics Inc. by a Wholly-Owned Subsidiary of JAG Media Boca Raton, FL, March 13, 2009 - - JAG Media Holdings, Inc. (OTCBB: JAGH) announced today that it has entered into a letter of intent with CardioGenics Inc. and its pri |
|
| March 13, 2009 |
REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of the 12th day of March 2009 (this “Agreement”) between YA GLOBAL MASTER SPV LTD. |
|
| March 13, 2009 |
STANDBY EQUITY DISTRIBUTION AGREEMENT STANDBY EQUITY DISTRIBUTION AGREEMENT THIS AGREEMENT dated as of the 12 day of March 2009 (this “Agreement”) between YA GLOBAL MASTER SPV LTD. |
|
| March 13, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 12, 2009 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commission F |
|
| December 30, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 30, 2008 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation (Commission |
|
| December 22, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended October 31, 2008. o Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 JAG MEDIA HOLDINGS, INC. (Exact name of registrant |
|
| December 16, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SEC File Number: 000-28761 CUSIP Number: 470080409 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨ Form 20-F ý Form 10-Q ¨ Form N-SAR For Period Ended: Quarter ended October 31, 2008 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR ¨ Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| November 13, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 to Form 10-K þ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended July 31, 2008 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 000-28 |
|
| November 13, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 Exhibit 10.10 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 November 12, 2008 Stephen J. Schoepfer c/o JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 Re: Extension of Amended and Restated Employment Agreement Dear Steve: This letter sets forth an agreement amending your current Amended and Restated Employment Agreement with JAG Media |
|
| November 13, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 Exhibit 10.9 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 November 12, 2008 Thomas J. Mazzarisi c/o JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 Re: Extension of Amended and Restated Employment Agreement Dear Tom: This letter sets forth an agreement amending your current Amended and Restated Employment Agreement with JAG Media Hol |
|
| November 13, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 Exhibit 10.9 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 November 12, 2008 Thomas J. Mazzarisi c/o JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 Re: Extension of Amended and Restated Employment Agreement Dear Tom: This letter sets forth an agreement amending your current Amended and Restated Employment Agreement with JAG Media Hol |
|
| November 13, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended July 31, 2008 OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number: 000-28761 JAG MEDIA HOLDINGS, INC. (E |
|
| November 13, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 Exhibit 10.10 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 November 12, 2008 Stephen J. Schoepfer c/o JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 Re: Extension of Amended and Restated Employment Agreement Dear Steve: This letter sets forth an agreement amending your current Amended and Restated Employment Agreement with JAG Media |
|
| October 3, 2008 |
Term Sheet JAG Media Holdings, Inc. (OTC PINK SHEETS: JAGH) and BlueCreek Energy, Inc. Merger of BlueCreek Energy, Inc. into a Wholly Owned Subsidiary of JAG Media Holdings, Inc. Dated: October 2, 2008 1. Target: BlueCreek Energy, Inc., a Colorado corporation, having a principal place of business at 621 17th Street, Suite 1140, Denver, CO 80293 (“BlueCreek”). 2. Issuer: JAG Media Holdings, Inc., a |
|
| October 3, 2008 |
Stephen J. Schoepfer, President & COO JAG Media Holdings, Inc. (609) 945-0405 [email protected] JAG Media Holdings, Inc. Announces Letter of Intent for the Merger of BlueCreek Energy, Inc. with a Wholly-Owned Subsidiary of JAG Media Boca Raton, FL, October 3, 2008 - JAG Media Holdings, Inc. (OTC PINK SHEETS: JAGH) announced today that it has entered into a non-binding letter of intent with BlueCr |
|
| October 3, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 3, 2008 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commission |
|
| October 3, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 September 30, 2008 YA Global Investments, L.P. 101 Hudson Street, Suite 3700 Jersey City, NJ 07302 Re: Warrants to purchase shares of JAG Media Holdings, Inc. (ÒJAG MediaÓ) held by YA Global Investments, L.P. (ÒYA GlobalÓ). Gentlemen: This letter shall set forth our understanding with respect to the warrant held by YA ( |
|
| June 20, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB x Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended April 30, 2008. o Transition report under Section 13 or 15(d) of the Exchange Act for the transition period from to . Commission file number 000-28761. JAG MEDIA HOLDINGS, INC. (Exact name of small bus |
|
| June 18, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 18, 2008 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commission Fi |
|
| June 18, 2008 |
Contact: Stephen J. Schoepfer, President & COO JAG Media Holdings, Inc. (888) 828-4174 [email protected] JAG Media Holdings, Inc. Announces Receipt of Letter from CryptoMetrics, Inc. Regarding No Further Extensions of Merger Agreement Boca Raton, FL, June 18, 2008 - JAG Media Holdings, Inc. (OTC PINK SHEETS: JAGH) announced today that it received a letter from CryptoMetrics, Inc. this morning whe |
|
| June 18, 2008 |
CRYPTOMETRICS, INC. 73 Main Street Tuckahoe, NY 10707 CRYPTOMETRICS, INC. 73 Main Street Tuckahoe, NY 10707 June 17, 2008 VIA FEDERAL EXPRESS AND FACSIMILE JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B-13 Boca Raton, FL 33433 Attn: Thomas J. Mazzarisi Facsimile: (561) 892-0821 Morgan, Lewis & Bockius LLP 101 Park Avenue New York, New York 10178 Attn: W. Preston Tollinger, Jr., Esq. Facsimile: (212) 309-6001 Re: Merger Agreement Among JAG Me |
|
| June 16, 2008 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12B-25 Commission File Number 000-28761 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 11-K ¨ Form 20-F ý Form 10-Q ¨ Form N-SAR For Period Ended: Quarter ended April 30, 2008 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR ¨ Transition Report on Form 11-K For the Transition Period Ended: Read attached instruction sheet before preparing form. |
|
| May 20, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 May 15, 2008 YA Global Investments, L.P. 101 Hudson Street Suite 3700 Jersey City, NJ 07302 Re: Letter Agreement between YA Global Investments, L.P. (“YA Global”) and JAG Media Holdings, Inc. (“JAG Media”) dated January 31, 2008, as amended by letter agreements between YA Global and JAG Media dated March 11, 2008, March |
|
| May 20, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 EX-10.1 2 v115197ex10-1.htm JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 May 15, 2008 YA Global Investments, L.P. 101 Hudson Street Suite 3700 Jersey City, NJ 07302 Re: Letter Agreement between YA Global Investments, L.P. (“YA Global”) and JAG Media Holdings, Inc. (“JAG Media”) dated January 31, 2008, as amended by letter agreements between YA Global and JAG Media |
|
| May 20, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 16, 2008 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commission Fil |
|
| May 20, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 16, 2008 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commission Fil |
|
| April 18, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 14, 2008 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commission F |
|
| April 18, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 April 14, 2008 Cryptometrics, Inc. 73 Main Street Tuckahoe, NY 10707 Re: Agreement Amending Merger Agreement Among JAG Media Holdings, Inc. (“JAG Media”), Cryptometrics Acquisition, Inc. (“Cryptometrics Acquisition”), Cryptometrics, Inc. (“Cryptometrics”), Robert Barra, Michael Vitale, Karlen & Stolzar, Thomas J. Mazzar |
|
| April 18, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 April 14, 2008 YA Global Investments, L.P. 101 Hudson Street Suite 3700 Jersey City, NJ 07302 Re: Letter Agreement between YA Global Investments, L.P. ("YA Global") and JAG Media Holdings, Inc. ("JAG Media") dated January 31, 2008, as amended by letter agreements between YA Global and JAG Media dated March 11, 2008 and |
|
| April 1, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 27, 2008 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commission F |
|
| April 1, 2008 |
JAG MEDIA HOLDINGS, INC. 6865 S.W. 18TH STREET, SUITE B13 BOCA RATON, FL 33433 JAG MEDIA HOLDINGS, INC. 6865 S.W. 18TH STREET, SUITE B13 BOCA RATON, FL 33433 March 27, 2008 YA Global Investments, L.P. 101 Hudson Street Suite 3700 Jersey City, NJ 07302 Re: Letter Agreement between YA Global Investments, L.P. (“YA Global”) and JAG Media Holdings, Inc. (“JAG Media”) dated January 31, 2008, as amended by letter agreement between YA Global and JAG Media dated March 11, 2008 (“YA |
|
| April 1, 2008 |
JAG MEDIA HOLDINGS, INC. 6865 S.W. 18TH STREET, SUITE B13 BOCA RATON, FL 33433 JAG MEDIA HOLDINGS, INC. 6865 S.W. 18TH STREET, SUITE B13 BOCA RATON, FL 33433 March 31, 2008 Cryptometrics, Inc. 73 Main Street Tuckahoe, NY 10707 Re: Agreement Amending Merger Agreement Among JAG Media Holdings, Inc. (“JAG Media”), Cryptometrics Acquisition, Inc. (“Cryptometrics Acquisition”), Cryptometrics, Inc. (“Cryptometrics”), Robert Barra, Michael Vitale, Karlen & Stolzar, Thomas J. Mazzar |
|
| April 1, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 27, 2008 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorporation) (Commission F |
|
| April 1, 2008 |
JAG MEDIA HOLDINGS, INC. 6865 S.W. 18TH STREET, SUITE B13 BOCA RATON, FL 33433 JAG MEDIA HOLDINGS, INC. 6865 S.W. 18TH STREET, SUITE B13 BOCA RATON, FL 33433 March 31, 2008 Cryptometrics, Inc. 73 Main Street Tuckahoe, NY 10707 Re: Agreement Amending Merger Agreement Among JAG Media Holdings, Inc. (“JAG Media”), Cryptometrics Acquisition, Inc. (“Cryptometrics Acquisition”), Cryptometrics, Inc. (“Cryptometrics”), Robert Barra, Michael Vitale, Karlen & Stolzar, Thomas J. Mazzar |
|
| April 1, 2008 |
JAG MEDIA HOLDINGS, INC. 6865 S.W. 18TH STREET, SUITE B13 BOCA RATON, FL 33433 JAG MEDIA HOLDINGS, INC. 6865 S.W. 18TH STREET, SUITE B13 BOCA RATON, FL 33433 March 27, 2008 YA Global Investments, L.P. 101 Hudson Street Suite 3700 Jersey City, NJ 07302 Re: Letter Agreement between YA Global Investments, L.P. (“YA Global”) and JAG Media Holdings, Inc. (“JAG Media”) dated January 31, 2008, as amended by letter agreement between YA Global and JAG Media dated March 11, 2008 (“YA |
|
| March 24, 2008 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q þ Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended January 31, 2008. o Transition report under Section 13 or 15(d) of the Exchange Act For the transition period from to . Commission file number 000-28761 JAG MEDIA HOLDINGS, INC. (Exact |
|
| March 18, 2008 |
OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2009 Estimated average burden hours per response . |
|
| March 17, 2008 |
FORM 8-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 14, 2008 |
EX-99.15: EXCLUSIVE PROVIDER AGREEMENT EX-99.15 Exhibit 99.15 Exclusive Provider Agreement The Agreement (dated April 1st, 2007) is entered into between CryptoMetrics, Inc., a company organized under the laws of the State of Delaware, USA (“CryptoMetrics”) and BioDentity Systems, LLC, a company organized under the laws of the United Arab Emirates (“BioDentity”). WHEREAS BioDentity wishes to provide the Government of the United Arab Emi |
|
| March 14, 2008 |
As filed with the Securities and Exchange Commission on March 14, 2008 S-4/A Table of Contents As filed with the Securities and Exchange Commission on March 14, 2008 Registration No. |
|
| March 13, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 EX-10.1 Exhibit 10.1 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 March 11, 2008 YA Global Investments, L.P. 101 Hudson Street Suite 3700 Jersey City, NJ 07302 Re: Letter Agreement between YA Global Investments, L.P. and JAG Media Holdings, Inc. dated January 31, 2008 (“YA Global Agreement”). Gentlemen: This will confirm our understanding that the terms and condit |
|
| March 13, 2008 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 11, 2008 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada (State or other jurisdiction of incorporation) 000-28761 (Commission File Num |
|
| March 13, 2008 |
As filed with the Securities and Exchange Commission on March 13, 2008 Table of Contents As filed with the Securities and Exchange Commission on March 13, 2008 Registration No. |
|
| March 13, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 EX-10.1 Exhibit 10.1 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 March 11, 2008 YA Global Investments, L.P. 101 Hudson Street Suite 3700 Jersey City, NJ 07302 Re: Letter Agreement between YA Global Investments, L.P. and JAG Media Holdings, Inc. dated January 31, 2008 (“YA Global Agreement”). Gentlemen: This will confirm our understanding that the terms and condit |
|
| March 13, 2008 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 11, 2008 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada (State or other jurisdiction of incorporation) 000-28761 (Commission File Num |
|
| March 5, 2008 |
As filed with the Securities and Exchange Commission on March 5, 2008 Table of Contents As filed with the Securities and Exchange Commission on March 5, 2008 Registration No. |
|
| February 8, 2008 |
As filed with the Securities and Exchange Commission on February 8, 2008 Table of Contents As filed with the Securities and Exchange Commission on February 8, 2008 Registration No. |
|
| February 7, 2008 |
Page 1 OMB APROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response?10/4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 6, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 EX-10.2 Exhibit 10.2 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 January 31, 2008 YA Global Investments, L.P. 101 Hudson Street Suite 3700 Jersey City, NJ 07302 Gentlemen: This will confirm our understanding that the terms and conditions of the Debentures, Warrants and other related documents between YA Global Investments, L.P. (“YA Global”) and JAG Media Holding |
|
| February 6, 2008 |
8-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 6, 2008 |
8-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 6, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 EX-10.1 Exhibit 10.1 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 February 6, 2008 Cryptometrics, Inc. 73 Main Street Tuckahoe, NY 10707 Re: Agreement Amending Merger Agreement Among JAG Media Holdings, Inc. (“JAG Media”), Cryptometrics Acquisition, Inc. (“Cryptometrics Acquisition”), Cryptometrics, Inc. (“Cryptometrics”), Robert Barra, Michael Vitale, Karlen & St |
|
| February 6, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 EX-10.1 Exhibit 10.1 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 February 6, 2008 Cryptometrics, Inc. 73 Main Street Tuckahoe, NY 10707 Re: Agreement Amending Merger Agreement Among JAG Media Holdings, Inc. (“JAG Media”), Cryptometrics Acquisition, Inc. (“Cryptometrics Acquisition”), Cryptometrics, Inc. (“Cryptometrics”), Robert Barra, Michael Vitale, Karlen & St |
|
| February 6, 2008 |
JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 Exhibit 10.2 JAG Media Holdings, Inc. 6865 S.W. 18th Street, Suite B13 Boca Raton, FL 33433 January 31, 2008 YA Global Investments, L.P. 101 Hudson Street Suite 3700 Jersey City, NJ 07302 Gentlemen: This will confirm our understanding that the terms and conditions of the Debentures, Warrants and other related documents between YA Global Investments, L.P. (?YA Global?) and JAG Media Holdings, Inc. |
|
| February 1, 2008 |
Page 1 OMB APROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response?10/4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 26, 2007 |
10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 21, 2007 |
LETTER TO THE S.E.C. David A. Sirignano Partner 202.739.5420 [email protected] December 20, 2007 VIA EDGAR Stephen Krikorian Accounting Branch Chief Division of Corporation Finance U.S. Securities and Exchange Commission 100 First Street, N.E. Washington, D.C. 20549 Re: Jag Media Holdings, Inc. Form 8-K Filed on November 14, 2007 File No. 000-28761 Dear Mr. Krikorian: Reference is made to |
|
| December 21, 2007 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 8, 2007 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorp |
|
| December 21, 2007 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 8, 2007 JAG Media Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-28761 88-0380546 (State or other jurisdiction of incorp |
|
| December 18, 2007 |
OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2009 Estimated average burden hours per response . |
|
| December 7, 2007 |
RW Thomas J. Mazzarisi Chairman & CEO [email protected] December 6, 2007 Division of Corporate Finance Securities and Exchange Commission Mail Stop 0408 Washington, D.C. 20549 ATTN: Duc Dang, Attorney Karen J. Garnett, Assistant Director RE: Registration Statement on Form S-4, File No. 333-141217 (the “2007 Registration Statement”) Ladies and Gentlemen: On behalf of JAG Media Holdings, Inc. |
|
| December 7, 2007 |
As filed with the Securities and Exchange Commission on December 7, 2007 Table of Contents As filed with the Securities and Exchange Commission on December 7, 2007 Registration No. |
|
| December 7, 2007 |
Thomas J. Mazzarisi Chairman & CEO [email protected] December 6, 2007 Division of Corporate Finance Securities and Exchange Commission Mail Stop 0408 Washington, D.C. 20549 ATTN: Duc Dang, Attorney Karen J. Garnett, Assistant Director RE: Registration Statement on Form S-4, File No. 333-131047 (the “2006 Registration Statement”) Ladies and Gentlemen: On behalf of JAG Media Holdings, Inc. (t |
|
| November 14, 2007 |
8-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 14, 2007 |
8-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
